论文部分内容阅读
背景:2009年3月,墨西哥、美国等多国暴发甲型H1N1流感疫情。5月10日,我国报告首例甲流病例,随后疫情蔓延全国。截至2009年底,全球已有1万多人死于甲型H1N1流感。为有效应对甲型H1N1流感疲情,2009年6月初,我国就开始着手甲型H1N1流感疫苗的临床试验,2009年9月7日,国家食品药品监管局签发了第一批可以实施免疫接种的合格的疫苗产品,中国成为世界上第一个可以应用甲型H1N1流感疫苗的国家。之后,包括中国在内的多个国家开始接种甲型H1N1流感疫苗,肆虐全球的甲型H1N1流感病毒有了克星。
Background: March 2009, Mexico, the United States and other multinational outbreaks of influenza A (H1N1) outbreaks. On May 10, China reported the first case of A-flow, and the epidemic spread throughout the country. As of the end of 2009, more than 10,000 people worldwide have died of Influenza A (H1N1). In order to effectively deal with the H1N1 influenza flu, in early June 2009, China started the clinical trial of Influenza A H1N1 influenza vaccine. On September 7, 2009, the State Food and Drug Administration issued the first batch of vaccines that can be vaccinated As a qualified vaccine product, China has become the first country in the world to apply the H1N1 influenza vaccine. Since then, many countries, including China, have started to receive the Influenza A (H1N1) vaccine, and the Noxivirus has hit the global H1N1 influenza virus.